PyInvesting

Market research

000504.SHE NanHua Bio-medicine Co., Ltd

SHE CNY Healthcare

Latest close

7.77 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
3B
P/E ratio
74.75
Analyst target
Not available
Dividend yield
Not available
Beta
0.34

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

NanHua Bio-medicine Co., Ltd is currently in a long term uptrend where the price is trading 43.7% above its 200 day moving average.

From a valuation standpoint, the stock is 122.2% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.4.

NanHua Bio-medicine Co., Ltd's total revenue rose by 61.4% to $71M since the same quarter in the previous year.

Its net income has dropped by 70.0% to $12M since the same quarter in the previous year.

Finally, its free cash flow fell by 1229.1% to $-204M since the same quarter in the previous year.

Based on the above factors, NanHua Bio-medicine Co., Ltd gets an overall score of 2/5.